University of Pittsburgh & Vizzhy Inc. Launch AI-Powered GAINMED Platform to Advance Precision Healthcare

The partnership has attracted a broad coalition of corporate collaborators, including L&T-Cloudfiniti, LTIMindtree, AWS, NVIDIA, Thermo Fisher Scientific, and others.

In a significant move towards personalized healthcare, the University of Pittsburgh has partnered with Bengaluru-based AI healthcare technology firm Vizzhy Inc. to launch GAINMED—an advanced AI-powered platform designed to deliver P5 Medicine: predictive, preventive, personalized, precision, and participatory care.

The initiative also includes creating Pitt-Vizzhy Longevity Labs, in collaboration with genomics giant Illumina Inc., to provide comprehensive multi-omics laboratory services. 

These labs will support the broader vision of expanding precision medicine both within the United States and internationally.

Multiomics at the Core of Personalized Care

Multiomics—a key component of this initiative—combines multiple layers of biological data such as genomics, proteomics, metabolomics, microbiomics, and epigenomics to offer a complete picture of an individual's biology. 

By integrating these data streams with AI and systems biology, GAINMED aims to optimize personal wellness and enable early disease detection, even before symptoms emerge.

"This is not just a scientific project. It's a public health mission," said Dr. Anantha Shekhar, senior vice chancellor for the health sciences and Dean of the School of Medicine at the University of Pittsburgh. 

He emphasized that Pittsburgh's infrastructure, institutional expertise, and community engagement uniquely position it to lead this global healthcare transformation.

GAINMED's Global Vision & Collaborations

Vizzhy Inc. co-founder Vishnu Vardhan cited Dr. Shekhar's vision for real-time clinical implementation of precision medicine as the key reason for choosing Pittsburgh as the base for GAINMED. 

"His leadership has built an environment where data science, clinical care, and human biology converge," Vardhan said.

The partnership has attracted a broad coalition of corporate collaborators, including L&T-Cloudfiniti, LTIMindtree, AWS, NVIDIA, Thermo Fisher Scientific, and others. 

These organizations are expected to support infrastructure, data science, and scaling efforts for the GAINMED platform and Longevity Labs.

The launch was followed by the "Pitt Med + AI: Transforming Global Health Symposium," which gathered international experts in AI, systems biology, and medicine. 

The event explored the future of P5 Medicine, challenges in data standardization, and ethical considerations related to data sharing and trust in healthcare AI.

With GAINMED, the University of Pittsburgh and Vizzhy Inc. aim to redefine healthcare delivery by transitioning from a reactive "sick care" model to a proactive, precision-driven health system.

Stay tuned for more such updates on Digital Health News.